Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Treatment and
Referral
Dr. Vida Hamilton
National Clinical Lead Sepsis
www.hse.ie/sepsis
Sepsis - 2
Regulated
o Innate & Adaptive
Cellular: Dendritic cells, T-cells, B-cells
PAMPs that bind TLR 2,3,4, Mannin-binding lecithin
receptors
(DAMPs)
Molecular: complement, acute phase, cytokines
Anti-viral: Interfon, local cellular immunity, apoptosis
Regulated?
Local inflammation
o Vasodilation, capillary leak
Systemic inflammation
o SIRS, CARS
Bone 1996
Hyperinflammatory response
Sepsis 1
Host
o Genetic polymorphisms
o Co-morbidities
Age
Chronic health status
Immuno-modulatory medications
More pathophysiology
Hotchkiss 2013
Dysregulated?
o Little necrosis
Apoptosis of the cellular immune system
Anti-inflammatory phase immunoparalysis
D4 persistent lymphopenia
Stimulate immune system improve outcome
Sepsis-3: A life threatening organ dysfunction
caused by a dysregulated host response to
infection
SOFA score
o Respiration: PaO2/FiO2 or SaO2/FiO2
o Coagulation: Platelets
o Liver: Bilirubin
o Cardiovascular: Hypotension or vasopressor
o CNS: GCS
o Renal: Creatinine or urinary output
qSOFA
o RR> 22, Altered Mental status, SBP <100
1o outcome: increased specificity in predicting
Mortality > 10%; ICU LOS > 3 days
The Burden
Common
Mortality: 20 - 55%
The Burden in Ireland
HIPE data:
Iwashyna et al: Long-term cognitive impairment & functional disability among survivors of severe sepsis.
JAMA, 2010.
Issues
Figure 3. Mean hospital mortality among patients with decreased lactate within 8 hours of index test, stratified by total fluid received in increments of
7.5 ml/kg based on medication administration record.
90
80
70
Percent in Compliance
60
50
40
30
20
10
0
Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15
Mortality
US 24%
Europe 28%
Bundle compliant 20%
Non-bundle compliant 30% p=0.026
HIPE: Diagnosis of Sepsis, Severe Sepsis
or Septic Shock in 2015
Crude
Number of Number of Mortality
Diagnosis Inpatients Deaths Rate
45.0%
40.0%
35.0%
Mortality Rate
30.0%
25.0%
20.0%
15.0%
10.0%
5.0%
0.0%